Abstract
Overactive bladder (urinary urgency and frequency with or without urge incontinence) affects as many as 40% of postmenopausal women. Behavior modification, pelvic floor exercises, and anticholinergic agents (e.g., oxybutynin chloride) are among first-line therapies; however, because side effects are common with such agents, topical estrogens are sometimes prescribed instead. In …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
